Renal angiomyolipomas: At least two diseases. A series of patients treated at two European institutions
Jean‐Baptiste Delhorme(Hôpitaux Universitaires de Strasbourg), Sylvie Bonvalot(Dana-Farber Cancer Institute), Dario Callegaro(Fondazione IRCCS Istituto Nazionale dei Tumori), Antonin Lévy(Inserm), Marco Fiore(Fondazione IRCCS Istituto Nazionale dei Tumori), C. Dratwa(Université Paris Sciences et Lettres), Andrea Fontana(Fondazione IRCCS Istituto Nazionale dei Tumori), Philippe Terrier(Institut Gustave Roussy), Alessandro Gronchi(Fondazione IRCCS Istituto Nazionale dei Tumori), Dimitri Tzanis(Université Paris Cité)
Cited by 18
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|751
Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services
|British journal of surgery|2020|719
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|641